(Q54540867)

31 May 2018

title

Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy (English)

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

16 April 2024

0 references

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

16 April 2024

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

16 April 2024

4

Bloomfield CD

1 reference

31 May 2018

3

Hurd DD

1 reference

31 May 2018

author name string

D. J. Hasbrouck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7289645

16 April 2024

B. A. Peterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7289645

16 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7289645

16 April 2024

publication date

1 January 1981

1 reference

31 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0145212681900084?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

https://api.elsevier.com/content/article/PII:0145212681900084?httpAccept=text/plain

16 April 2024

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

16 April 2024

1 reference

31 May 2018

volume

5

1 reference

31 May 2018

issue

4-5

1 reference

31 May 2018

page(s)

357-361

1 reference

31 May 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

High remission-induction rate in acute myeloid leukaemia

16 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features

16 April 2024

5

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia

16 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

16 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia

16 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat

16 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

Predicting response to combination chemotherapy in acute myeloblastic leukemia--- a way to individualize treatment.

16 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look

16 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/0145-2126(81)90008-4

16 April 2024

Identifiers

1 reference

31 May 2018

1 reference

31 May 2018